Searched for
ABHAY SHANBHAG
- Ranbaxy and Dr Reddy's to take a hit as Lipitor market shrinks 96%Analysts expect prices of atorvastatin, generic version of Lipitor, to drop further as additional players enter the market.16 Jun, 2012, 04.38 AM IST
- Ranbaxy falls 7% to nine-month low on USFDA settlement costsAnalysts said Ranbaxy could lose millions of dollars in potential revenues and undergo a time consuming process before it resume supplies28 Jan, 2012, 03.34 AM IST
- Pfizer marketing may hit Ranbaxy’s profit from low-cost lipitor versionLate last year, Pfizer started offering ‘co-pay’ programmes which lowered out of pocket payment by insured patients to $4 a month for a Lip...14 Nov, 2011, 03.55 AM IST
- USFDA bans sale of medicines from DRL's Mexico facility, warns CadilaThe USFDA on Wednesday banned the US sale of medicines made at Dr Reddy's Mexican facility and sent a warning to letter Cadila Healthcare f...07 Jul, 2011, 05.01 AM IST
- Ranbaxy shares fall by 8.7% after report of $1 billion US FDA fineThe proposed penalty on Ranbaxy reported by Fortune magazine is more than double of what the industry has been speculating.06 May, 2011, 01.12 AM IST
- Good time to buy infra stocks, not fundsInfrastructure stocks are available at very low valuations and can be good long-term buys. Taking the mutual fund route may not be that pro...31 Jan, 2011, 12.41 PM IST
Load More- Ranbaxy and Dr Reddy's to take a hit as Lipitor market shrinks 96%
